Tonix Pharma Fibromyalgia Treatment Associated with Improvement in Pain, Sleep, FatigueBenzinga • 06/03/21
Tonix Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational HighlightsGlobeNewsWire • 05/10/21
Tonix Pharma: Interesting Molecule In Fibromyalgia, But Generic Availability Is A ConcernSeeking Alpha • 05/02/21
Tonix Pharmaceuticals to Participate in Fourth Annual Neuroscience Innovation ForumGlobeNewsWire • 04/21/21
Tonix Pharma Stock Is Trading Higher On Expanding COVID-19 Candidate Portfolio With Sangivamycin Licensing PactBenzinga • 04/19/21
Tonix Pharmaceuticals Announces Results of Pre-IND Meeting with FDA on TNX-601 CR for the Treatment of Major Depressive DisorderGlobeNewsWire • 03/22/21
Tonix Pharmaceuticals Announces Issuance of U.S. Patent for Compositions and Uses of Tianeptine Oxalate Salt, the Active Ingredient of TNX-601 CRGlobeNewsWire • 03/19/21
Tonix Pharma's COVID-19 Vaccine Candidate Shows Encouraging Efficacy In Animal StudiesBenzinga • 03/17/21
Tonix Pharmaceuticals Reports Positive COVID-19 Vaccine Efficacy Results in Non-Human Primates Vaccinated with TNX-1800 and Challenged with Live SARS-CoV-2GlobeNewsWire • 03/17/21
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational HighlightsGlobeNewsWire • 03/15/21
